London

London is Europe’s leading research finance and policy hub, home to world-class universities, the Francis Crick Institute, and the headquarters of some of the world’s largest corporate R&D organizations. Melan works with teams across London’s research ecosystem to structure cross-border partnerships that connect UK science with global industry.


The London Research Partnership Landscape

London’s research ecosystem is anchored by a concentration of global universities: Imperial College London (science, engineering, and medicine), University College London (the largest research university in the UK by grant income), King’s College London, the London School of Economics, Queen Mary University of London, and Royal Holloway. The Francis Crick Institute — a £700 million biomedical research center — is a partnership between six of the UK’s most successful research organizations.

Corporate R&D is well-represented through UK headquarters and research labs of GlaxoSmithKline, AstraZeneca, Shell, BP, and Unilever, alongside the growing tech R&D presence of DeepMind (Google AI), Microsoft Research Cambridge (linked to London), and Meta AI. The Alan Turing Institute is the UK’s national institute for data science and artificial intelligence, based at the British Library.

Post-Brexit, London’s research partnerships face new complexity around Horizon Europe association, regulatory alignment, and talent mobility. Melan navigates these challenges to help UK and European organizations build partnerships that work within the new framework.


What Melan Does for Teams in London

Melan helps London’s research institutions connect with global corporate partners and helps international companies access UK research capacity.

For corporate R&D teams in London: We map the UK research landscape to identify university partners aligned with your priorities — from Imperial’s strength in climate technology and engineering to UCL’s leadership in biomedical research. We structure partnerships that account for UK grant funding mechanisms, charity research support, and Horizon Europe participation models.

For London universities and institutes: We help TTOs and research offices identify corporate partners who value UK research excellence, navigate the increasingly complex international partnership landscape, and structure collaborations that comply with UKRI and charity funding requirements.

For international companies entering the UK market: We provide strategic guidance on accessing UK research infrastructure — catapult centers, innovation hubs, and university partnerships — and structure collaborations that leverage UK tax incentives for R&D.


FAQ

How does Melan help companies partner with Imperial or UCL?

We map the specific research groups and PIs aligned with your R&D priorities, then approach Imperial’s Industry Partnerships and Commercialisation team or UCL Business with a pre-structured framework tailored to UKRI funding and Charity research rules.

What makes London unique for research partnerships?

London combines elite research universities with the UK’s policy, finance, and legal infrastructure for science. It’s the gateway to European research partnerships and UKRI funding programs — with a concentration of talent and capital that rivals any global city.

Does Melan work with UK biotech and pharma companies?

Yes. We work with GSK, AstraZeneca, and UK-based biotechs to identify academic partners across the Crick Institute, Imperial, UCL, and the broader UK biomedical research ecosystem.

How do I start a research partnership in London?

Contact Melan at themelan.com/contact-us. We discuss your R&D priorities and map the London research ecosystem to identify the right collaborators for your goals.


Ready to form a research partnership in London?

Melan helps corporate R&D teams, universities, and research institutes across London structure successful research collaborations.

Speak to Our Team →

Have a unique project in mind? Let's talk.

Melan connects corporations, researchers, labs, and foundations with the technology partnerships they need to move further, faster.